I-Kobaktan yamakati

I-antibiotics group cephalosporins sekuyisikhathi eside isetshenziselwa ukwelashwa kanye nemithi yezilwane. Kodwa maduze nje, kwakungenzeka ukudala ukulungiswa kwesizukulwane se-IV - iKobaktan (cefkinoma sulfate). Ngakho-ke, ama-analogues omuthi we-Kobaktan (cefazolinum, ceftriaxone, cefotaxin nabanye), okungokwesizukulwane sesithathu saleli qembu lama-antibiotics, kuye ezindaweni eziningi kuncane kakhulu. Lesi sici siphumelele ngempumelelo ngophekisa ubuso ezinkukhunjini, imastitis ezinkomeni, izilonda zamahhashi amahhashi emahhashi, izilonda ezihlukahlukene ngezinselo. Kodwa abathandi bamakati nezinja bangathatha le mithi ngenothi. Izinhlobo eziningi ze-pathogenic ezisongela izilwane zethu ezifuywayo ezifuywayo zenza ukuthi zizwele ku-cefkina.

I-Kobaktan yamakati - imfundo

1. Yini ephethe umuthi uKobaktan emakati?

Lo muthi ungabhalwa ngezifo ezilandelayo emakati: izifo zendlela yokuphefumula (uma amabhaktheriya abonisa ukuzwela ku-Kobaktan), i-arthritis, i-meningitis, i- cystitis , i-urethritis, izifo ezithile zesikhumba .

2. Isilinganiso somuthi weKobaktan.

Amakati, i-antibiotic Kobaktan ijojowe ngokujova 0.5 ml wokulungiselela ku-5 kg ​​wesisindo somzimba ngesilwane ngosuku. Inkambo yokwelapha ivame ukuvela ezinsukwini ezimbili kuya kwezingu-5. Phakathi kwamajojo, isikhathi sokuhamba isikhathi amahora angu-24. Kunconywa ukuhlola isiguli ngomsindo we-cefkium sulfate ngaphambi kokuqala ukwelashwa.

3. I-Cefkin ine-half-life short and is excreted by the kidneys.
4. Ukuphikiswa kwesidakamizwa iKobaktan ngamakati cishe ayiphuthuki.
5. Izinga lokwelapha lezinto ezisebenzayo kufinyelelwa emaminithini ambalwa emva kokujola. Ngaphezu kwakho konke, itholakala emcimbini we-bronchial.
6. Ngenxa yokuthi ama-preservatives kanye nezimo eziqinile azisetshenziswanga kulo muthi, i-Cobactan ayifuni neze ukudala izifo. Ngokuvamile ukusabela kwendawo kulawo ama tishu esakhiweni somjovo ngokuvamile kuzinqamuka ngokwabo phakathi kwamasonto amabili.
7. I-Kobaktan yamakati cishe ayifaki emathunjini omzimba, ngakho-ke i-dysbacteriosis, evame ukutholakala nge-antibiotic therapy, kuleli cala cishe ayifakiwe.

Kuye kwafakazelwa isipiliyoni ukuthi ngisho nokuphindwe kabili kwesilinganiso sokunconywa kweKobaktan ezimweni eziningi cishe akuzange kubangele imiphumela emibi. Kodwa siyaqaphela ukuthi izivivinyo ezinjalo zokuziphatha ngaphezu kwezilwane ezifuywayo ziyingozi kakhulu. Nakuba i-Kobaktan yamakati futhi inobuthi obuthakathaka, kodwa kungcono ukuyilawula ngaphansi kokuqondiswa kwezilwane zezilwane kanye nokulinganisa okunconywayo.